Clinical Trial

Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke

Study acronym: SUCRE
Recruiting
View on ClinicalTrials.gov →
Summary
Stroke is a leading cause of disability and the second leading cause of death worldwide. Most strokes are ischemic, caused by acute arterial occlusion. Post-stroke treatment focuses on secondary prevention and rehabilitation, but few treatments address functional recovery. Creatine, a supplement known for improving physical performance, may aid in the recovery of stroke patients, reducing sarcopenia and improving strength among other effects. This pilot study will investigate the effectiveness of creatine supplementation in enhancing physical and functional recovery in ischemic stroke patients. The study will involve a randomized, double-blind clinical trial comparing creatine monohydrate to a placebo.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-26; most recent amendment 2025-07-02.
Status change: Not Yet Recruiting → Recruiting 2024-10-16
Trial Details
NCT Number NCT06576466
Lead Sponsor Fundació d'investigació Sanitària de les Illes Balears
Collaborators: Comunidad Autónoma de las Islas Baleares (Dirección General de Investigación en Salud, Formación y Acreditación)
Conditions Stroke, Ischemic
Enrollment 92 participants
Start Date 2024-09-27
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-08